Exclusive Orphan Drug Content

Thought Leaders in Rare Disease & Orphan Drug News

Uniting to Meet the Challenge of Rare Diseases in 2022 and Beyond

Author: Jeff Somers

Around the world, a renewed focus on rare diseases and orphan drugs is beginning to move the needle – but there is more work to do.

Why It's an Exciting Time in Rare Disease Drug Development

With Mediaplanet & USA Today 

Experts from the World Orphan Drug Congress USA 2022 discuss the factors enabling better research and development of rare disease drugs, and what can be done to improve the field in the future.